Regional Research Centres

Once-daily dolutegravir versus raltegravir in antiretroviral-naive adults with HIV-1 infection: 48 week results from the randomised, double-blind, non-inferiority SPRING-2 study

François Raffi, Anita Rachlis, Hans‐Jürgen Stellbrink et al. · The Lancet · 2013 · 537 citations

Week Results, Treatment And Prevention, Human Retrovirus +8

Comparison of Once-Daily Atazanavir With Efavirenz, Each in Combination With Fixed-Dose Zidovudine and Lamivudine, As Initial Therapy for Patients Infected With HIV

Kathleen Squires, Adriano Lazzarin, Jos M. Gatell et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 2004 · 299 citations

Situational factors influencing drug injecting, risk reduction and syringe exchange in Togliatti City, Russian Federation: a qualitative study of micro risk environment

Tim Rhodes, Larissa Mikhailova, Anya Sarang et al. · Social Science & Medicine · 2003 · 237 citations

Drug Safety, Russian Federation, Global Health +8

Undetectable equals untransmittable (U = U): awareness and associations with health outcomes among people living with HIV in 25 countries

Chinyere Okoli, Nicolas Van de Velde, Bruce W. Richman et al. · Sexually Transmitted Infections · 2020 · 150 citations · Full text

Explosive spread and high prevalence of HIV infection among injecting drug users in Togliatti City, Russia

Tim Rhodes, Catherine M Lowndes, Ali Judd et al. · AIDS · 2002 · 149 citations